CV Sciences (CVSI) Non-Current Assets (2013 - 2026)
CV Sciences' (CVSI) quarterly Non-Current Assets came in at $1.7 million in Q1 2026, down 3.95% year-on-year from $1.8 million in Q1 2025, and down 5.58% quarter-over-quarter from $1.8 million in Q4 2025.
CV Sciences (CVSI) Non-Current Assets (2013 - 2026) Analysis & Trends
CV Sciences has disclosed Non-Current Assets across 14 years of filings, most recently posting $1.7 million for Q1 2026.
- Non-Current Assets for Q1 2026 came in at $1.7 million, down 3.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.5 million (up 2.51% YoY), and the FY2025 annual result was $1.8 million, up 8.61% from the prior year.
- Non-Current Assets came in at $1.7 million for Q1 2026 at CV Sciences, down from $1.8 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $3.2 million in Q1 2022 to a low of $1.1 million in Q1 2024.
- The 5-year median for Non-Current Assets is $1.7 million (2026), against an average of $1.9 million.
- Across the five-year window, Non-Current Assets plunged 75.6% in 2022 and jumped 61.83% in 2024, its largest moves.
- CV Sciences' Non-Current Assets stood at $1.6 million in 2022, then declined by 21.42% to $1.3 million in 2023, then surged by 33.44% to $1.7 million in 2024, then increased by 8.61% to $1.8 million in 2025, then declined by 5.58% to $1.7 million in 2026.
- The last three Non-Current Assets figures came in at $1.7 million (Q1 2026), $1.8 million (Q4 2025), and $1.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 26.33 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 8.68 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 3.84 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 2.47 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 9.64 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 2.90 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.40 Bn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 1.22 Bn |
| 10 | CV Sciences | - | - | 1.56 Mn | 1.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.73 Mn |
| Dec 31, 2025 | 1.83 Mn |
| Sep 30, 2025 | 1.90 Mn |
| Jun 30, 2025 | 2.01 Mn |
| Mar 31, 2025 | 1.80 Mn |
| Dec 31, 2024 | 1.68 Mn |
| Sep 30, 2024 | 1.64 Mn |
| Jun 30, 2024 | 2.15 Mn |
| Mar 31, 2024 | 1.12 Mn |
| Dec 31, 2023 | 1.26 Mn |
| Sep 30, 2023 | 1.19 Mn |
| Jun 30, 2023 | 1.33 Mn |
| Mar 31, 2023 | 1.47 Mn |
| Dec 31, 2022 | 1.61 Mn |
| Sep 30, 2022 | 2.98 Mn |
| Jun 30, 2022 | 3.12 Mn |
| Mar 31, 2022 | 3.21 Mn |
| Dec 31, 2021 | 3.88 Mn |
| Sep 30, 2021 | 9.40 Mn |
| Jun 30, 2021 | 12.78 Mn |